3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1438
Pancreatic Neoplasms
862
Carcinoma, Hepatocellular
745
Stomach Neoplasms
650
Colonic Neoplasms
448
Rectal Neoplasms
406
Esophageal Neoplasms
400
Breast Neoplasms
332
Carcinoma, Non-Small-Cell Lung
328
Neoplasms
307
Liver Neoplasms
283
Cholangiocarcinoma
244
Ovarian Neoplasms
243
Lung Neoplasms
239
Neoplasm Metastasis
237
Gastrointestinal Neoplasms
219
Melanoma
186
Esophageal Squamous Cell Carcinoma
167
Prostatic Neoplasms
166
Biliary Tract Neoplasms
161
Endometrial Neoplasms
143
Uterine Cervical Neoplasms
130
Squamous Cell Carcinoma of Head and Neck
129
Head and Neck Neoplasms
114
Carcinoma, Renal Cell
114
Sarcoma
101
Urinary Bladder Neoplasms
97
Adenocarcinoma Of Esophagus
90
Triple Negative Breast Neoplasms
87
Anus Neoplasms
83
Interventions
Pyloromyotomy
1
Botulinum Toxins, Type A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Motility Disorders
×
Gastrointestinal
×
1 year
×
Clear all
NCT06721520
2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3
Recruiting
170 enrolled